A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...

NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally. This designation is ...

The average dividend yield in the S&P 500 Index remains low at around 1.3%. As a result, many stocks have lower dividend ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

The American College of Cardiology has established the Connect-HCM digital registry to broaden understanding of, improve access to care for, hypertrophic cardiomyopathy, one of the most common genetic ...

Jonathan Thompson, MD, MS, highlighted that reducing delays in molecular testing and treatment initiation is critical for improving lung cancer outcomes, and that clinical trial data suggest ...

New Jersey high schools shine in a recent U.S. News ranking, with High Technology High School in Lincroft taking the lead as ...

During a live event, Tian Zhang, MD, MHS, discussed options and recent trial data for treating metastatic hormone-sensitive ...

Agilent (A) announced that its MMR IHC Panel pharmDx has received FDA approval as a companion diagnostic test for colorectal cancer. This test ...

PD-1 Inhibitor Drug PD-1 Inhibitor Drugs Market poised for robust growth, driven by rising cancer therapies and expanding immuno-oncology a ...

Bristol-Myers Squibb Company announced a significant update on their Phase 3 lung cancer trial. The study tests two promising ...